Extracellular Iron is a Modulator of the Differentiation of Osteoclast Lineage Cells

被引:54
作者
Xie, Wenjie [1 ,2 ,3 ]
Lorenz, Sebastian [4 ]
Dolder, Silvia [1 ]
Hofstetter, Willy [1 ,2 ]
机构
[1] Univ Bern, Dept Clin Res, Bone Biol & Orthopaed Res, Murtenstr 35, CH-3010 Bern, Switzerland
[2] Univ Bern, NCCR TransCure, Swiss Natl Ctr Competence Res, CH-3010 Bern, Switzerland
[3] Univ Bern, Grad Sch Cellular & Biomed Sci, CH-3010 Bern, Switzerland
[4] City Hosp Triemli Zurich, Inst Lab Med, Zurich, Switzerland
关键词
Osteoclast; RANKL; DMT1; Ferroportin; TfR1; TUMOR-NECROSIS-FACTOR; BONE-RESORPTION; FACTOR-ALPHA; OSTEOPOROSIS; DEFICIENCY; PRECURSORS; PATHOGENESIS; INHIBITOR; MICE; PUMP;
D O I
10.1007/s00223-015-0087-1
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Osteoclasts originate from the hematopoietic stem cell and share a differentiation pathway with the cells of the monocyte/macrophage lineages. Development and activation of osteoclasts, and as a consequence regulation of bone resorption, depend on two growth factors: macrophage colony-stimulating factor and receptor activator of NF-kappa B ligand. Furthermore, cell development and activity are modulated by a microenvironment composed of cytokines and growth factors and of the extracellular matrix. Membrane transporters are a means for cells to interact with their environment. Within this study, the expression of proteins regulating cellular iron homeostasis in osteoclast-like cells grown from bone marrow-derived progenitors was compared to the expression of this set of proteins by monocyte/macrophage lineage cells. In differentiating osteoclasts, levels of transcripts encoding transferrin receptor 1 and divalent metal transporter 1 (Slc11A2) were increased, while levels of transcripts encoding ferroportin (Slc40A1) and natural resistance-associated macrophage protein 1 (Slc11A1) were decreased. Supplementation of the culture media with exogenous iron led to an increase in the proliferation of osteoclast progenitor cells and to the expression of a macrophage-like phenotype, while the development of osteoclasts was reduced. Upon transfer of mature OC onto a CaP substrate, iron depletion of the medium with the Fe 3?-chelator Deferoxamine Mesylate decreased CaP dissolution by similar to 30 %, which could be restored by addition of exogenous iron. During the 24 h of the assay, no effects were observed on total TRAP activity. The data demonstrate transcriptional regulation of the components of cellular iron transporters during OC development and suggests that iron homeostasis may contribute to fine-tuning of the RANKL-induced OC development.
引用
收藏
页码:275 / 283
页数:9
相关论文
共 41 条
[1]
TNFα inhibits the development of osteoclasts through osteoblast-derived GM-CSF [J].
Atanga, Elvis ;
Dolder, Silvia ;
Dauwalder, Tina ;
Wettervvald, Antoinette ;
Hofstetter, Willy .
BONE, 2011, 49 (05) :1090-1100
[2]
Interleukin-17A Stimulates Granulocyte-Macrophage Colony-Stimulating Factor Release by Murine Osteoblasts in the Presence of 1,25-Dihydroxyvitamin D3 and Inhibits Murine Osteoclast Development In Vitro [J].
Balani, Deepak ;
Aeberli, Daniel ;
Hofstetter, Willy ;
Seitz, Michael .
ARTHRITIS AND RHEUMATISM, 2013, 65 (02) :436-446
[3]
Tumor necrosis factor-alpha: Alternative role as an inhibitor of osteoclast formation in vitro [J].
Balga, Renate ;
Wetterwald, Antoinette ;
Portenier, Jeannette ;
Dolder, Silvia ;
Mueller, Christoph ;
Hofstetter, Willy .
BONE, 2006, 39 (02) :325-335
[4]
Molecular regulation of osteoclast activity [J].
Bruzzaniti, Angela ;
Baron, Roland .
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2006, 7 (1-2) :123-139
[5]
Incorporation of RANKL promotes osteoclast formation and osteoclast activity on β-TCP ceramics [J].
Choy, John ;
Albers, Christoph E. ;
Siebenrock, Klaus A. ;
Dolder, Silvia ;
Hofstetter, Wilhelm ;
Klenke, Frank M. .
BONE, 2014, 69 :80-88
[6]
NORMAL AND PATHOLOGICAL REMODELING OF HUMAN TRABECULAR BONE - 3-DIMENSIONAL RECONSTRUCTION OF THE REMODELING SEQUENCE IN NORMALS AND IN METABOLIC BONE-DISEASE [J].
ERIKSEN, EF .
ENDOCRINE REVIEWS, 1986, 7 (04) :379-408
[7]
Recent developments in the understanding of the pathophysiology of osteopetrosis [J].
Felix, R ;
Hofstetter, W ;
Cecchini, MG .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1996, 134 (02) :143-156
[8]
FELIX R, 1990, J BONE MINER RES, V5, P781
[9]
Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383
[10]
Cellular iron: Ferroportin is the only way out [J].
Ganz, T .
CELL METABOLISM, 2005, 1 (03) :155-157